Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 11491
TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620574(US20230303494, Compound 37)
Affinity DataKd:  67.5nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548981(CHEMBL4790354 | US20230303494, Compound 11)
Affinity DataKd:  0.515nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548982(CHEMBL4783983 | US20230303494, Compound 10)
Affinity DataKd:  0.296nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548983(CHEMBL4795176 | US20230303494, Compound 5)
Affinity DataKd:  0.0160nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548985(CHEMBL4792711 | US20230303494, Compound 4)
Affinity DataKd:  1.81nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548983(CHEMBL4795176 | US20230303494, Compound 5)
Affinity DataIC50: 12nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548999(CHEMBL4762340 | US20230303494, Compound 22)
Affinity DataIC50: 17nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620555(US20230303494, Compound 18)
Affinity DataIC50: 23nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548995(CHEMBL4745173 | US20230303494, Compound 21)
Affinity DataIC50: 24nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620550(US20230303494, Compound 13)
Affinity DataIC50: 26nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620569(US20230303494, Compound 32)
Affinity DataIC50: 31nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548998(CHEMBL4797033 | US20230303494, Compound 23)
Affinity DataIC50: 36nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548982(CHEMBL4783983 | US20230303494, Compound 10)
Affinity DataIC50: 38nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620572(US20230303494, Compound 35)
Affinity DataIC50: 44nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548994(CHEMBL4797328 | US20230303494, Compound 25)
Affinity DataIC50: 47nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549009(CHEMBL4776320 | US20230303494, Compound 17)
Affinity DataIC50: 92nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548981(CHEMBL4790354 | US20230303494, Compound 11)
Affinity DataIC50: 107nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620573(US20230303494, Compound 36)
Affinity DataIC50: 131nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549011(CHEMBL4745438 | US20230303494, Compound 19)
Affinity DataIC50: 165nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50239947(US9872852, Example 202 | CHEMBL4089730 | US2023030...)
Affinity DataIC50: 175nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548986(CHEMBL4791785 | US20230303494, Compound 28)
Affinity DataIC50: 191nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620568(US20230303494, Compound 31)
Affinity DataIC50: 206nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620551(US20230303494, Compound 14)
Affinity DataIC50: 253nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620574(US20230303494, Compound 37)
Affinity DataIC50: 323nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549003(CHEMBL4743978 | US20230303494, Compound 20)
Affinity DataIC50: 347nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620544(US20230303494, Compound 7)
Affinity DataIC50: 363nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549002(CHEMBL4754315 | US20230303494, Compound 34)
Affinity DataIC50: 435nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620543(US20230303494, Compound 6)
Affinity DataIC50: 436nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548990(CHEMBL4754010 | US20230303494, Compound 29)
Affinity DataIC50: 610nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620570(US20230303494, Compound 33)
Affinity DataIC50: 637nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549012(CHEMBL4785837 | US20230303494, Compound 8)
Affinity DataIC50: 672nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620575(US20230303494, Compound 38)
Affinity DataIC50: 1.04E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548985(CHEMBL4792711 | US20230303494, Compound 4)
Affinity DataIC50: 1.16E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548997(CHEMBL4794520 | US20230303494, Compound 24)
Affinity DataIC50: 1.33E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM620553(US20230303494, Compound 16)
Affinity DataIC50: 2.58E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549014(CHEMBL4793439 | US20230303494, Compound 3)
Affinity DataIC50: 2.60E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549005(CHEMBL4743124 | US20230303494, Compound 15)
Affinity DataIC50: 2.63E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548989(CHEMBL4753463 | US20230303494, Compound 30)
Affinity DataIC50: 2.93E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549015(CHEMBL4754792 | US20230303494, Compound 2)
Affinity DataIC50: 3.67E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549017(CHEMBL4786497 | US20230303494, Compound 9)
Affinity DataIC50: 4.24E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549006(CHEMBL4758875 | US20230303494, Compound 12)
Affinity DataIC50: 4.54E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50549016(CHEMBL4763554 | US20230303494, Compound 1)
Affinity DataIC50: 4.94E+3nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548987(CHEMBL4752793 | US20230303494, Compound 27)
Affinity DataIC50: 2.26E+4nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent

TargetProgrammed cell death 1 ligand/protein 1(Human)
Academy of Military Medical Sciences

US Patent
LigandPNGBDBM50548988(CHEMBL4755673 | US20230303494, Compound 26)
Affinity DataIC50: 1.00E+5nMAssay Description:Example 39: The experimental method and procedure were carried out in accordance with the kit instructions, which were briefly described as follows: ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
Go to US Patent